Guidelines state that women with rheumatoid arthritis should be screened for anti-Ro/La autoantibodies [4]; however, these antibodies are less prevalent in this group than in those diagnosed with SLE [15]. The gene discussed is CALR; the disease is rheumatoid arthritis.